Abstract

Introduction: The occurrence of two main symptoms (calcification of the falx cerebri, odontogenic keratocysts, basal cell carcinoma) and a minimum of one secondary symptom is necessary for de-novo diagnosing a Basal Cell Nevus Syndrome (BCNS). Late diagnosing is usual if the primary symptoms are absent. Subtypes of BCNS may express phenotypes at different ages. Early recognition is needed. The adhesion of keratocysts to the basal bone layer varies, so different treatment options are standard. Aim: A 47-year-old woman without clinical signs of BCNS except macrocephaly suffered from de-novomutation of the PTCH1 gene. Odontogenic keratocysts were recognized sporadically by CB-CT ten years later, as late-onset; Compared to subsequent generations, who often present the main symptoms in childhood. The indication of resection, marsupialization, or enucleation with or without Carnoy-solution is a clinical decision. Conclusion: Despite 100% penetrance, intrafamilial expression of the clinical phenomenon is variable. In child morbidity, the parents’ lifelong co-screening should be mandatory by radiological and clinical investigation. Late-onset KCOT should be resected en-bloc, including soft tissue movement. Enucleation has less morbidity for mandibular keratocysts near the nerve. Carnoy-solution helps minimize the risk of relapse.

Highlights

  • The occurrence of two main symptoms and a minimum of one secondary symptom is necessary for de-novo diagnosing a Basal Cell Nevus Syndrome (BCNS)

  • Aim: A 47-year-old woman without clinical signs of BCNS except macrocephaly suffered from de-novomutation of the Protein Patched Homolog 1 (PTCH1) gene

  • Radical resection of late-onset keratocystic odontogenic tumors (KCOT) appears to be a sure option in syndromic cases, including soft tissue movement

Read more

Summary

Introduction

Gorlin-Goltz-Syndrome (basal cell nevus syndrome (BCNS)) is wellknown for a prevalence of 1:50.000 to 1:150.000 and was first described by Gorlin et al in 1960 [1]. It is a hereditary disease, an autosomal dominant trait characterized by high penetration and variable phenotypical expression [2]. Pathognomonic for BCNS are keratocystic odontogenic tumors (KCOT) in the jaws and multiple basal cell carcinomas. They should be carefully detected [6,7,8,9]. A CB-CT is favourable for diagnostic reasons [10, 11]

Aim
Diagnosis
Treatment
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.